Gradient Investments LLC Novo Nordisk A S Transaction History

Gradient Investments LLC

$3.79 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$122.71 - $146.91 $122 - $146	-1 Reduced 0.16%	609 $86,000
Q1 2024 Apr 23, 2024	SELL	$102.11 - $135.92 $464,804 - $618,707	-4,552 Reduced 88.18%	610 $78,000
Q4 2023 Jan 18, 2024	SELL	$87.78 - $105.45 $144,398 - $173,465	-1,645 Reduced 24.17%	5,162 $534,000
Q3 2023 Oct 27, 2023	BUY	$90.94 - $199.54 $325,019 - $713,155	3,574 Added 110.55%	6,807 $619,000
Q2 2023 Jul 11, 2023	SELL	$155.98 - $172.65 $28,700 - $31,767	-184 Reduced 5.38%	3,233 $523,000
Q1 2023 Apr 17, 2023	SELL	$132.34 - $159.14 $66,302 - $79,729	-501 Reduced 12.79%	3,417 $543,000
Q4 2022 Jan 10, 2023	SELL	$102.55 - $135.33 $62,247 - $82,145	-607 Reduced 13.41%	3,918 $0
Q3 2022 Oct 14, 2022	SELL	$95.28 - $116.93 $21,342 - $26,192	-224 Reduced 4.72%	4,525 $451,000
Q2 2022 Jul 11, 2022	BUY	$103.24 - $121.81 $20,854 - $24,605	202 Added 4.44%	4,749 $529,000
Q1 2022 May 26, 2022	BUY	$93.1 - $112.54 $379,103 - $458,262	4,072 Added 857.26%	4,547 $505,000
Q4 2021 Jan 12, 2022	SELL	$95.88 - $117.08 $61,842 - $75,516	-645 Reduced 57.59%	475 $53,000
Q3 2021 Oct 18, 2021	BUY	$84.42 - $106.62 $5,487 - $6,930	65 Added 6.16%	1,120 $108,000
Q2 2021 Jul 12, 2021	SELL	$67.66 - $84.76 $420,845 - $527,207	-6,220 Reduced 85.5%	1,055 $88,000
Q1 2021 Apr 21, 2021	SELL	$67.06 - $75.82 $27,762 - $31,389	-414 Reduced 5.38%	7,275 $490,000
Q4 2020 Jan 08, 2021	SELL	$63.89 - $73.8 $46,000 - $53,136	-720 Reduced 8.56%	7,689 $534,000
Q3 2020 Oct 06, 2020	SELL	$63.69 - $70.22 $14,776 - $16,291	-232 Reduced 2.68%	8,409 $584,000
Q2 2020 Jul 10, 2020	SELL	$58.54 - $67.94 $781,567 - $907,066	-13,351 Reduced 60.71%	8,641 $566,000
Q1 2020 Apr 07, 2020	SELL	$49.46 - $64.78 $174,593 - $228,673	-3,530 Reduced 13.83%	21,992 $1.32 Million
Q4 2019 Jan 15, 2020	SELL	$49.86 - $58.26 $110,041 - $128,579	-2,207 Reduced 7.96%	25,522 $1.48 Million
Q3 2019 Oct 10, 2019	SELL	$47.54 - $53.43 $246,162 - $276,660	-5,178 Reduced 15.74%	27,729 $1.43 Million
Q2 2019 Jul 16, 2019	BUY	$46.79 - $52.47 $426,256 - $478,001	9,110 Added 38.28%	32,907 $1.68 Million
Q1 2019 Apr 11, 2019	SELL	$46.36 - $52.63 $877,594 - $996,285	-18,930 Reduced 44.3%	23,797 $1.25 Million
Q4 2018 Jan 18, 2019	SELL	$41.54 - $47.25 $218,168 - $248,157	-5,252 Reduced 10.95%	42,727 $1.97 Million
Q3 2018 Oct 11, 2018	BUY	$46.76 - $51.24 $77,902 - $85,365	1,666 Added 3.6%	47,979 $2.26 Million
Q2 2018 Aug 09, 2018	BUY	$44.29 - $50.42 $318,932 - $363,074	7,201 Added 18.41%	46,313 $2.14 Million
Q1 2018 Apr 11, 2018	BUY	$48.49 - $58.14 $177,279 - $212,559	3,656 Added 10.31%	39,112 $1.93 Million
Q4 2017 Feb 07, 2018	BUY	$47.53 - $53.73 $315,789 - $356,982	6,644 Added 23.06%	35,456 $1.9 Million
Q3 2017 Oct 16, 2017	BUY	$41.15 - $49.22 $1.19 Million - $1.42 Million	28,812	28,812 $1.39 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$1.76 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.26 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.25 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.16 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.07 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.

Account